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Abstract 
Cryptosporidium parvum is a major cause of diarrhoea in humans and animals. There are no 
vaccines and few drugs available to control C. parvum. In this study, we used RNA-Seq to compare 
gene expression in sporozoites and intracellular stages of C. parvum to identify genes likely to be 
important for successful completion of the parasite’s life cycle and, thereby, possible targets for 
drugs or vaccines. We identified 3774 protein-encoding transcripts in C. parvum. Applying a 
stringent cut-off of eight fold for determination of differential expression, we identified 173 genes 
(26 coding for predicted secreted proteins) upregulated in sporozoites. On the other hand, 
expression of 1259 genes was upregulated in intestinal stages (merozoites/gamonts) with a gene 
ontology enrichment for 63 biological processes and upregulation of 117 genes in 23 metabolic 
pathways. There was no clear stage specificity of expression of AP2-domain containing 
transcription factors, although sporozoites had a relatively small repertoire of these important 
regulators. Our RNA-Seq analysis revealed a new calcium-dependent protein kinase, bringing the 
total number of known Calcium-dependent protein kinases (CDPKs) in C. parvum to 11. One of 
these, CDPK1, was expressed in all stages, strengthening the notion that it is a valid drug target. By 
comparing parasites grown in vivo (which produce bona fide thick-walled oocysts) and in vitro 
(which are arrested in sexual development prior to oocyst generation) we were able to confirm that 
genes for oocyst wall proteins are expressed in gametocytes and the proteins stockpiled rather than 
generated de novo in zygotes. RNA-Seq analysis of C. parvum revealed genes that are expressed in 
a stage-specific manner and others whose expression is required at all stages of development. The 
functional significance of these can now be addressed through recent advances in transgenics for C. 
parvum, and may lead to the identification of viable drug and vaccine targets. 
 
Keywords:  Cryptosporidium parvum; Apicomplexa; Calf; Transcriptome; Sporozoites; Intestinal 
stages; in vitro stages; Intervention targets 
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1. Introduction 
Cryptosporidium is a genus of apicomplexan parasites recognised as one of the four main 
causes of diarrhoea in young children and, hence, a major contributor to early childhood mortality 
worldwide (Kotloff et al., 2013; Striepen, 2013; Checkley et al., 2015; Ryan and Hijjawi, 2015; 
Certad et al., 2017. Furthermore, Cryptosporidia are significant causes of potentially fatal diarrhoea 
in AIDS patients (Morgan et al., 2000). They are also extremely problematic in livestock, causing 
profuse diarrhoea and considerable economic losses in young calves and lambs in industrialised 
agriculture (Joachim et al., 2003; O'Handley and Olson, 2006). Although nearly 20 species and 
genotypes of Cryptosporidium have been recorded in humans (Ryan and Hijjawi, 2015), the vast 
majority of cases associated with diarrhoea in humans are caused by Cryptosporidium hominis or 
Cryptosporidium parvum (Certad et al., 2017) Whilst the former appears to be largely human-
specific, the latter is also a significant cause of disease in cattle and, thus, a parasite of substantial 
zoonotic concern (Abeywardena et al., 2015). 
 Numerous developmental and molecular peculiarities indicate that Cryptosporidium spp. are 
more closely related to a primitive group of apicomplexans, the gregarines, than to coccidian 
parasites such as Toxoplasma gondii or Eimeria spp. (reviewed recently (Ryan and Hijjawi, 2015)). 
However, the developmental life cycles of, for example, C. hominis and C. parvum, are 
superficially similar to classic enteric coccidian development. Thus, infection follows a faecal-oral 
route and begins with the ingestion of sporulated oocysts. Sporozoites are released in the small 
intestine shortly after ingestion, invade enterocytes and form intracellular parasitophorous vacuoles 
at the apical surface of host cells, but remain extracytoplasmic. Within these, type I meronts 
develop, forming eight merozoites. Merozoites released from type I meronts either repeat this 
proliferative step or progress to type II meronts, containing four merozoites. The latter transform 
into the sexual stages, i.e., macrogametocytes, whose prominent wall-forming bodies can be readily 
detected in thin section transmission electron micrographs, or microgametocytes containing bullet-
shaped microgametes, which are more difficult to identify. Fertilisation leads to the formation of 
oocysts that sporulate in the intestine (endogenous sporulation) without forming sporocysts and are 
immediately infectious upon shedding. There is an unresolved controversy about the ability of 
Cryptosporidium to replicate outside of a host organism (Clode et al., 2015). 
 There are no vaccines or chemoprophylactics to prevent infection with Cryptosporidium and 
very few chemotherapeutic options for its treatment (Checkley et al., 2015). New opportunities to 
uncover targets for drugs are inherent in the availability of genome sequence databases for C. 
parvum (Abrahamsen et al., 2004) and C. hominis (Abrahamsen et al., 2004) and the development 
of technologies for the genetic manipulation of the former parasite (Vinayak et al., 2015). The 
Cryptosporidium genome has several unique features: it is markedly reduced (at around 9 million 
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bases and <4,000 genes) compared with other enteric apicomplexans (e.g., ~52 million bases and 
>9,000 genes for Eimeria tenella, ~63 million bases and >8,000 genes for T. gondii), displaying 
streamlined metabolic pathways, minimal modes of energy production and an inability to synthesise 
essential building blocks for amino acid, purine, and fatty acid synthesis. It lacks an apicoplast, due 
to secondary reduction, and has a reduced mitochondrion (mitosome) without a role in energy 
metabolism (Keeling, 2004). Thus, C. parvum relies heavily on nutrient acquisition from the 
host (Abrahamsen et al., 2004; Xu et al., 2010) and, arguably, its commensal bacterial flora for 
intracellular survival. All these features of Cryptosporidium result in many of the unique anti-
apicomplexan drug targets being absent. Moreover, the complexity and limitations of the available, 
reliably reproducible and highly productive in vitro cultivation protocols, as well as the lack of 
robust small animal models for reproducing the entire Cryptosporidium life cycle, make new target 
identification and validation somewhat challenging. 
 Comparative RNA-Seq analysis can be exploited to uncover critical molecules and 
pathways in enteric parasite development; we have recently used such approaches to highlight 
unique expression profiles in the development of T. gondii in the cat small intestine (Walker et al., 
2015) and E. tenella in the caeca of chickens (Walker et al., 2015). In this study, we use similar 
strategies to compare C. parvum stages prepared from the small intestinal epithelium of 
experimentally infected calves with parasites propagated in vitro. The latter proliferate efficiently as 
merozoites but they apparently lack the ability to differentiate to oocysts in culture, and can be 
considered arrested in sexual development. Hence, we used comparative analysis of gene 
expression as a means to identify factors likely to be relevant for successful sexual development and 
oocyst formation. In contrast to most intestinal apicomplexans, sporulation ensues without delay in 
Cryptosporidium, resulting in excretion of infectious oocysts containing fully developed 
sporozoites, which can be considered a stable developmental end point in terms of their mRNA 
complement until they invade a new host cell to develop into first generation merozoites. Thus, 
RNA-Seq data of sporozoites from purified oocysts completes the full characterisation of 
developmental gene expression during the Cryptosporidium life cycle. 
 
2. Materials and methods 
2.1. Preparation of parasites and RNA 
Oocysts of a field strain of C. parvum, IPZ:CH-Crypto_K6769, were purified from faeces 
using a protocol published previously (Meloni and Thompson, 1996). The purity and identification 
of these oocysts as C. parvum “cattle genotype” was confirmed using PCR and direct sequencing of 
a fragment of the 18S rDNA using published methods (Ward et al., 2002). Oocysts of C. parvum 
IPZ:CH-Crypto_K6769 were stored in PBS with antibiotic/antimycotic solution (Sigma-Aldrich, 
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Switzerland) and passaged regularly through calves purchased from farms in the Canton of Zurich 
(Switzerland) at 1-3 days of age prior to experimental infections; calves were confirmed to be 
Cryptosporidium-free prior to experimental inoculation by modified Ziehl-Neelsen stain and by 
coproantigen detection (Bio-X Diagnostics®). The calves were housed in an experimental animal 
facility of the Institute of Parasitology of the University of Zürich, Switzerland. Individual calves 
were housed in pens of ~9 m2 on a litter of straw and sawdust over a rubber mat on a concrete base. 
The pens were cleaned daily. Calves were fed ad libitum with a commercial milk substitute 
(UFA200) supplied by an automatic dispenser. Water and hay were also provided ad libitum. 
 Biological material for RNA extraction and RNA-Seq analysis was generated using in vivo 
and in vitro stages as well as freshly excysted sporozoites. For the former, a calf was inoculated 
orally with 2.5 x 109 oocysts and euthanised 47 h p.i. (day 2). Subsequently, another calf was 
inoculated orally with 1.2 x 109 oocysts and sacrificed 93 h p.i. (day 4). The small intestine was 
immediately removed and chilled on ice. All subsequent processing of tissue was done using pre-
chilled solutions in a 4 °C cold room. Each small intestine was divided into five segments of equal 
length. In step 1, all segments were rinsed with PBS and then filled with HBSS (w/o Mg2+/Ca2+) / 
2 mM DTT / 5 mM EDTA, ligated and incubated for 15-30 min. The HBSS wash fraction was then 
collected and stored on ice for parasite enrichment. In step 2, the five segments were each divided 
into two parts. Part 1 was filled with HBSS (w/o Mg2+/Ca2+) / 5 mM EDTA, ligated and incubated 
for another 15-20 min. The liquid was collected and added to the HBSS wash collected in Step 1. 
Part 2 was filled with 80 ml of trypsin-EDTA solution (Sigma, 3924, diluted 1:1 with PBS) and 
incubated for approximately 25 min. Trypsin was inactivated by adding 40 ml of FCS and this 
liquid was also added to the HBSS wash collected in Step 1. The combined material was pelleted 
and then mixed with RLT buffer (guanidine thiocyanate lysis buffer) (supplemented with 10 µl of 
2-mercaptoethanol/ml buffer, RNeasy® Mini- or Midikit, QIAGEN). The resulting lysate was 
passed eight times through a 20-gauge needle fitted to an RNase-free syringe. The homogenised 
solution was then shock frozen in liquid nitrogen and stored at –80°C until RNA preparation. 
 In preparation for in vitro infections with C. parvum, HCT-8 cells (human ileocecal 
adenocarcinoma cells, ATCC, CCL-244) were cultured in a humidified incubator at 37°C and 5% 
CO2 as described previously (Upton et al., 1995). Culture medium (RPMI 1640 with L- glutamine, 
5% heat inactivated FCS, 5% Optimem+Glutamax, 1 mM sodium pyruvate, 50 U/ml of penicillin 
G, 50 U/ml of streptomycin, 0.25 µg/ml of amphotericin B, and 50 µg/ml of gentamycin) was 
changed every 48-72 h as required. Confluent (minimum 95%) T75 tissue culture flasks were used 
for in vitro culture. The monolayer was washed twice with pre-warmed PBS and cells were covered 
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with 5 ml of infection medium (RPMI 1640 with L-glutamine, 5% Optimem+Glutamax, 1 mM 
sodium pyruvate, 50 U/ml of penicillin G, 50 U/ml of streptomycin, 0.25 µg/ml of amphotericin B, 
and 50 µg/ml of gentamycin, 500 µg/ml of taurocholic acid sodium salt hydrate, 15 mM HEPES). 
To infect the HCT-8 cells, 4.6x106 oocysts were re-suspended in 10 mM hydrochloric acid, 
incubated for 10 min at 37 °C and pelleted thereafter. The pellet was re-suspended with culture 
medium and was added to the HCT-8 cells. After 2 h of incubation, cells were washed twice with 
10 ml of pre-warmed PBS to remove unexcysted oocysts and free sporozoites, and 15 ml of pre-
warmed long-term infection medium (infection medium supplemented with 5 ml of heat inactivated 
FCS, 1 µg/ml of folic acid, 4 µg/ml of 4-aminobenzoic acid, 2 µg/ml of D-pantothenic acid 
hemicalcium, 0.1 U/ml of Caninsulin (Intervet), 35 µg/µl of L-ascorbic acid and, 50 mM glucose) 
were added. The medium was exchanged every 24 h, as described previously(Upton et al., 1995). 
After 48 h and 96 h of in vitro cultivation, the medium was removed and cells were washed twice 
with ice-cold PBS to remove free parasites, cell debris and floating cells. Another 10 ml of ice-cold 
PBS were added and infected cells were scraped away and pelleted at 4 °C. Pelleted material was 
mixed with RLT buffer (supplemented with 10 µl of 2-mercaptoethanol/ml buffer, RNeasy® Mini-
Kit, QIAGEN, Switzerland). The cells were lysed by centrifugation using a QiaShredder 
(QIAGEN) and processed immediately for RNA preparation. 
 To isolate sporozoites, oocysts were centrifuged at 6000 g for 2 min at room temperature. 
The resulting pellet was re-suspended in 10 mM HCl and incubated for 10 min at 37°C. Parasites 
were centrifuged again and re-suspended in 2 mM sodium taurocholate (Sigma)/PBS and incubated 
at 37°C for 16 min. Excystation rates of over 95% were reached. Pelleted parasites were mixed with 
RLT buffer (supplemented with 10 µl of 2-mercaptoethanol/ml of buffer, RNeasy® Mini-Kit, 
QIAGEN). The lysate was centrifuged through a QiaShredder (QIAGEN) and immediately 
processed for RNA preparation. 
 Total RNA was isolated from the various samples using a RNeasy® mini- or midikit 
(QIAGEN) following the manufacturer’s instructions including an on-column DNase I digestion 
(RNase free DNase-Set, QIAGEN). Total RNA was enriched for mRNA in two rounds using the 
MicroPolyA Purist Kit (Thermo Fisher Scientific, Switzerland). The RNA was quantified using a 
Qubit fluorometer (Thermo Fisher Scientific, Switzerland) and its quality was analysed with a 
Bioanalyzer 2100 (Agilent, Switzerland) and the Agilent 6000 Pico kit (Supplementary Fig. S1). 
 
2.2. cDNA library construction and RNA-Seq 
Genome-wide transcriptome libraries were produced from duplicate biological samples for 
parasites harvested from calf intestines 2 and 4 days p.i. with C. parvum oocysts, parasites 
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harvested from in vitro cultures 2 and 4 days post-inoculation, and from sporozoites purified from 
oocysts, using protocols previously described by us (Schnyder et al., 2009). The transcriptome 
libraries (0.5 pM) were used for emulsion PCR. The barcoded libraries were pooled prior to 
performing emulsion PCR and the resulting beads were loaded onto either full SOLiD 4 slides 
(Applied Biosystems, Switzerland), for the in vivo samples, or on to SOLiD 5500xl chips (Applied 
Biosystems) for in vitro and sporozoite samples, following the manufacturer’s instructions. SOLiD 
ToP Sequencing chemistry was used to produce pair end (50 bp + 35 bp for SOLiD 4, 75 bp + 35 
bp for SOLiD 5500xl) sequencing reads. 
 Short reads generated in this study were deposited at NCBI Sequence Read Archive (SRA, 
www.ncbi.nlm.nih.gov/sra) and are accessible through the accession number SRP069013. To 
remove potential contamination with host RNA, reads of the in vitro and the in vivo/sporozoite 
samples were first aligned to the human or bovine genomes, respectively (ensembl82) with Subread 
(version 1.4.6-p4, options -B 10 -m 5; (Liao et al., 2013)). Reads without an alignment were then 
aligned to the C. parvum Iowa II genome (CryptoDB 8.0) with Subread allowing up to 10 
alignments per read (options: -H -B 10 -m 5, only forward F5 reads). Count tables were generated 
with the annotation from CryptoDB (release 8.0, http://cryptodb.org/common/downloads/release-
8.0/CparvumIowaII/gff/data/CryptoDB-8.0_CparvumIowaII.gff) and with Rcount (Schmid and 
Grossniklaus, 2015) with an allocation distance of 50 bp for calculation of the weights of the reads 
with multiple alignments, consideration of the strand information, and a minimal number of five 
hits. Technical replicates (two each for sporozoites, in vivo 2 days p.i. and in vivo 4 days p.i.) were 
summed. Read counts of < 5 were considered not expressed and were set to 0. Variation in gene 
expression was analysed with a general linear model in R with the package DESeq2 (version 1.10.0, 
(Love et al., 2014)) according to a factorial design with the two explanatory factors ORIG 
(sporozoites, in vitro, and in vivo) and TIME (2/4 days p.i.) combined into a single factor. Specific 
conditions were compared with linear contrasts and P values were adjusted for multiple testing 
(Benjamini-Hochberg). Genes with an adjusted P value below 0.05 were considered to be 
differentially expressed. 
 
2.3. BLAST, Blast2GO and alignments 
Protein domains were identified using a Simple Modular Architecture Research Tool 
(SMART (Schultz et al., 1998). A protein BLAST search was performed using the NCBI webtool 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) with subsequent SmartBLAST analysis. Protein sequences 
retrieved from CryptoDB (Puiu et al., 2004) release 26, www.cryptodb.org) were used for a BLAST 
search using Blast2GO (version 3.1.3). Alignments were performed using the MUSCLE tool on 
http://www.ebi.ac.uk/Tools/msa/muscle/. 
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2.4. Ethics statement 
Housing of, and experimentation on, calves was conducted with approval and under the 
supervision of the Cantonal Veterinary Office and the Ethics Committee of the Canton of Zurich 
(Kantonales Veterinaeramt Zurich, Obstgartenstrasse 21, 8090, Zurich, Switzerland) and carried out 
according to Swiss Law and Guidelines on Animal Welfare, and the specific regulations of the 
Canton of Zurich under Permit Number 161/2009. 
 
3. Results and Discussion 
3.1. Isolation of parasites and RNA-Seq analysis 
A completed and annotated genome sequence for C. parvum (CryptoDB, release 8.0 and 
Blast2GO, Supplementary Table S1) provided the basis for analysis of gene expression during the 
life cycle (Abrahamsen et al., 2004). Previous studies of C. parvum gene expression considered 
mRNA levels of specific sets of genes and/or developmental stages (Mullapudi et al., 2007; Zhang 
et al., 2012), or used proteomics to analyse a specific stage (i.e. sporozoites) (Sanderson et al., 
2008; Siddiki, 2013). Although the latter gave valuable qualitative information on expression of 
approximately one-third of the ~3700 gene models in CryptoDB, the information was neither 
comprehensive nor suitable for comparative analysis. Here, we used quantitative RNA-Seq analysis 
to explore gene expression at a genome-wide level and in different developmental stages isolated 
form experimentally infected animals and cell cultures. 
 RNA was isolated from the in vitro cultivated C. parvum, infected calf intestines 
(Supplementary Fig. S2A) and excysted sporozoites (Supplementary Fig. S2B), enriched for mRNA 
and sequenced on a SOLiD platform. For read mapping, we used the C. parvum Iowa II genome 
sequence.  
 To identify differentially expressed genes, we used the genome annotation from CryptoDB 
(release 8.0) and Blast2GO (Supplementary Table S1). Correlations in gene expression between the 
samples were plotted (Supplementary Fig. S3); due to the distinct gene expression patterns in the 
sporozoite samples, the comparative analyses of the proliferation stages isolated from calves or cell 
culture were performed separately. As expected, the highest number of reads mapping to C. parvum 
genes was obtained for sporozoites due to low contamination of the sample with host material 
(Supplementary Table S2). Overall, we found evidence for expression of 3763 genes (3802 
including the sporozoite data), from which transcripts not encoding proteins (e.g. rRNAs, small 
nucleolar RNAs (snoRNAs), tRNA, etc.) were removed to obtain 3744 (3774 with sporozoites) 
protein-encoding transcripts in total (Supplementary Table S3 and S4). Normalisation and 
differential analyses were performed using DEseq2 (Love et al., 2014). Pair-wise, hierarchical 
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clustering using all genes in all samples showed that the sporozoite sample formed a separate clade 
whilst the in vivo and the in vitro samples formed two distinctly separate clades (Fig. 1A). The four 
in vitro samples as well as the two in vivo samples appear highly correlated and all six samples are 
more similar to each other than to the sporozoite datasets. For a more in-depth analysis of the in 
vivo and in vitro samples, the data were subjected to correlation analysis excluding the sporozoite 
samples (Fig. 1B). All in vitro samples formed one clade with the two replicates at each time point 
forming subclades. However, there was a high overall correlation between the samples. Only minor 
differences in gene expression were observed between the time points in the in vitro and in vivo 
samples, probably due to a mixture of various developmental stages. This highlights the difficulties 
in sampling distinct developmental stages for C. parvum whose life cycle is very rapid. We 
therefore combined the two time points for the in vitro and in vivo samples for differential gene 
expression analysis. One thousand, four hundred and forty-one differentially expressed genes (i.e., 
>4-fold difference in normalised reads) were identified with more than half of these genes being 
down-regulated in sporozoites (Fig. 1C). More detailed analyses of these samples, excluding the 
sporozoite dataset, showed that 496 genes are differentially expressed (i.e., >4-fold difference in 
normalised reads) between both in vitro samples and in vivo samples, with approximately half of 
the genes down-regulated in in vitro samples and half upregulated (Fig. 1D). Differential expression 
between sporozoites and the in vivo or in vitro stages, as well as between the latter two stages, was 
analysed (using data including and excluding the sporozoites; non-protein coding, snoRNA, rRNA 
and tRNA removed; Supplementary Tables S5-S10). Comparison of the up- and down-regulated 
genes between the samples showed that more than 1000 genes were more highly expressed in 
sporozoites than in the in vivo or in vitro stages, respectively (Fig. 1E), which corresponds to 30.9% 
and 27.6% of the total protein coding genes. In contrast, expression of 559 and 605 genes was lower 
in sporozoites compared with the in vivo or in vitro stages, respectively, representing 14.7% and 
15.9% of all protein-encoding genes. Three hundred and twenty-eight genes were more highly 
expressed in the in vivo stages compared with the in vitro sample, whilst expression of 220 genes 
was lower, corresponding to 8.6% and 5.8%, respectively, of all genes (Fig. 1E). 
 
3.2. Analysis of differential expression in vivo and in vitro 
Propagation of C. parvum in continuous culture in hollow fiber systems (Morada et al., 
2016) has yielded bona fide thick-walled oocysts whilst less complex culture systems on cell 
monolayers (Upton et al., 1994a; Upton et al., 1994b; Castellanos-Gonzalez et al., 2013) led to 
production of thin walled oocysts only, if any (Arrowood, 2002). We attempted to explore this 
apparent arrest in development of bona fide oocysts to identify differences in expression profiles 
between unproductive sexual development in in vitro culture and infection in vivo. For in vitro 
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cultivation, we essentially followed the protocol for infection of HCT-8 cell monolayers (Upton et 
al., 1995), which resulted in robust amplification of the parasite population but did not yield any 
observable oocysts within the 4 day time frame used in these experiments. Cultured parasites were 
harvested at the same time points as those in experimental infections (i.e., 2 days and 4 days p.i.) for 
RNA extraction and analysis of gene expression. Application of a higher cut-off for differential 
expression, i.e., at least four-fold difference in mRNA levels (normalised reads/kb), was used to 
compare in vivo and in vitro samples. Due to the minor differences (Fig. 1B), biological replicate 
samples (in vitro samples only) were averaged, as were sampling time points, allowing for a global 
comparison of in vitro and in vivo gene expression (Supplementary Table S5-S10). Combining the 
day 2 and 4 samples for both the in vitro and in vivo sample sets is further supported by the 
observation that the sexual phase of development, exemplified here by expression of 
Cryptosporidium oocyst wall protein (COWP) genes (Fig. 2), occurs as early as day 2 p.i. in vivo, 
as indicated in the existing literature (O'Donoghue, 1995). Using these criteria, we found higher 
expression of 55 and 253 genes in vitro and in vivo, respectively. However, parsing of those 
samples using gene ontology (Blast2Go) revealed no basis for a robust biological interpretation of 
the developmental block of in vitro cultured parasites. Nevertheless, the analysis showed that 59 of 
the 253 significantly more highly expressed genes in the combined in vivo dataset encode for 
predicted secreted proteins. This group also contains eight genes coding for proteins larger than 100 
kDa. Among those is CpCOWP1, one of the three most abundant oocyst wall proteins (Sanderson et 
al., 2008) (see also Section 3.5). Whether the seven other very large secreted proteins in this group 
are as yet unidentified structural components of the oocyst remains to be investigated. Conversely, 
in the group of genes with higher expression in vitro, parsing according to gene ontology terms 
showed a surprisingly large representation of genes involved in biological processes such as 
DNA/chromatin organisation, DNA metabolism, and nucleosome organisation (43% of all hits), 
whilst only six genes coding for secreted proteins were identified. The significant expression of 
major and minor COWPs in vitro points to an arrest late in sexual development, which may explain 
the paucity of biological information gained from a comparison with in vivo stages.  
 
3.3. Differential gene expression in sporozoites 
Correlation analysis revealed major differences in gene expression in sporozoites compared 
with parasites replicating intracellularly (Fig. 1A). Using stringent cut-offs for calling regulated 
genes in a comparison of sporozoites and in vivo samples, we identified only 161 genes (25 coding 
for predicted secreted proteins) with at least eight-fold higher normalised reads in sporozoites. On 
the other hand, 1095 genes were at least eight-fold more highly expressed in intestinal stages 
(merozoites/gamonts, Supplementary Table S5-S10) with a gene ontology enrichment for 63 
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biological processes and significant upregulation of 117 genes in 23 metabolic pathways. General 
upregulation of metabolism features most prominently in this comparative analysis after parsing the 
subset of intestinal stage-regulated genes according to biological processes or molecular function. 
While the mechanisms of gene expression regulation in Cryptosporidium are not well explored 
(Mullapudi et al., 2007; Oberstaller et al., 2013; Oberstaller et al., 2014), systematic analysis of 
genes with similar expression profiles from cultured parasites has produced direct evidence for co-
regulation by ApiAP2 and other transcription factors (Oberstaller et al., 2013; Oberstaller et al., 
2014). Using the datasets produced by Oberstaller et al. (2013) we could not find clustered 
distribution for any of the 200 co-regulated sets of genes. Similarly, we found that genes expressed 
at higher levels in sporozoites or the intestinal stage did not cluster more frequently on the eight 
C. parvum chromosomes than random samples of equal size (data not shown). 
 
3.4. Expression profiles of the C. parvum ApiAP2 transcription factors 
The apicomplexan Apetala2 transcription factors (apiAP2) have been shown to regulate 
gene expression before or during stage transition (Yuda et al., 2009; Yuda et al., 2010; Iwanaga et 
al., 2012; Radke et al., 2013; Walker et al., 2013a; Yuda et al., 2015) as well as be involved in 
virulence and host cell invasion (Walker et al., 2013b). A comprehensive analysis of the AP2-
domain containing transcription factors in C. parvum has been described by Oberstaller et al. 
(Oberstaller et al., 2014). Using their list of identified transcription factors and our Blast2GO 
analysis (Supplementary Table S1), we analysed their expression in the different life cycle stages of 
C. parvum. We found that two putative genes encoding AP2-domain containing transcription 
factors, cgd8_3230 (predicted to be an ApiAP2XI-3) and cgd6_2600 are >4-fold upregulated in 
sporozoites compared with the in vitro and >20-fold compared to the in vivo stages (Fig. 3). 
Interestingly, sporozoites seem to have a small repertoire of ApiAP2. The only gene upregulated in 
vitro is the predicted ApiAP2IV-2 gene (cgd5_4250) showing >2-fold more reads than the in vivo 
sample and >12-fold more than the sporozoites. More than four-fold and two-fold upregulation in 
vivo versus in vitro can be seen for cgd5_2570 and cgd6_1140 (predicted as apiAP2VIII-5 and 
ApiAP2X-11), respectively. However, none of these regulated transcription factors are exclusively 
stage-specific. This may be linked to the observed redundancy in the C. parvum ApiAP2-binding 
motifs (Oberstaller et al., 2014). Further analyses of the downstream targets and stage specificity 
can now be addressed through recent developments in transgenesis (Vinayak et al., 2015). 
 
3.5. Macrogamete-associated genes 
Components of the oocyst walls in Cryptosporidium spp. are secreted from wall forming 
bodies (Spano et al., 1997; Aldeyarbi and Karanis, 2016) in the macrogametocyte that contain inter 
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alia COWP proteins. As expression of COWP genes is specific to macrogametocytes, they are good 
indicators for sexual stage development (Smith et al., 2005). Consistent with previous observations 
(Upton et al., 1995), we found considerable expression of the more abundant COWPs in the culture-
derived samples at both time-points but not as high as in the samples collected from experimentally 
infected calves (Fig. 2). Expression of all COWPs in sporozoites was silenced. 
 
3.6. Mucins 
Mucins are heavily glycosylated proteins that are involved in Cryptosporidium host cell 
attachment and/or invasion (Cevallos et al., 2000; O'Connor et al., 2009) and tethering of 
sporozoites to the oocyst wall (Chatterjee et al., 2010), and are bound by the lectin Maclura 
pomifera agglutinin (MPA). Our data revealed that gp900 (cgd7_4020), previously shown to be on 
the sporozoite surface and involved in mediating host cell attachment (Cevallos et al., 2000), is 
expressed mainly in in vivo stages and to a lesser extent in sporozoites (Fig. 4). However, we 
detected mucin gp40/15 (cgd6_1080) in in vivo and in vitro stages, but not in sporozoites (Fig. 4) in 
contrast to previous studies where the protein was detected in merozoites and sporozoites 
(O’Connor et al., 2007) and shown to play a role in host cell attachment (Cevallos et al., 2000). 
CpMuc5 (cgd2_430) has been shown to be expressed in all intestinal stages and has been localized 
to merozoites and sporozoites (O'Connor et al., 2009); our data confirm expression in all stages with 
upregulation in sporozoites (Fig. 4). Only another mucin gene, cgd4_3550, present in all stages, is 
up-regulated in sporozoites (Fig. 4). Taken together, we find mucins mainly expressed in the 
intestinal stages with very few expressed additionally in sporozoites. 
 Based on this analysis, we conclude that macrogamete development including expression of 
oocyst wall genes occurs readily in vitro. Further research is required to address the question of 
whether successful development to thick-walled, environmentally resistant and infectious oocysts is 
dependent on additional factors conferred by the cell culture system (e.g., a more complex cellular 
ecosystem) or on fertilisation by microgametes. 
 Chatterjee et al. (2010) (Chatterjee et al., 2010) used MS analysis of excysted or sonicated 
oocyst walls to determine the abundance of oocyst wall proteins (COWP1-9). Their findings 
correlate exactly with our RNA-Seq analysis, i.e., COWPs 1, 6 and 8 being the most abundant, 
followed by significantly lower levels of COWPs 2, 3 and 4. COWPs 5, 7, and 9 are present in very 
low amounts. However, whilst Chatterjee et al. (2010) concluded that CpMPA4 is an oocyst wall-
associated protein, our analyses reveal that it is, in fact, most highly expressed in sporozoites. 
 
3.7. Microgamete-associated genes  
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In contrast to biflagellate microgametes from Coccidia, Cryptosporidium male gametes are 
bullet shaped with a large, elongated nucleus surrounded by microtubules and an apical adhesive 
zone (Vetterling et al., 1971; Bird and Smith, 1980; Goebel and Braendler, 1982; Landsberg and 
Paperna, 1986; Fayer et al., 1990; Ostrovska and Paperna, 1990; Cheadle et al., 1999; Alvarez-
Pellitero and Sitja-Bobadilla, 2002; Akiyoshi et al., 2003). To date, no exclusively flagellar 
components have been identified (Bird and Smith, 1980) and it is not known if microgametes move 
actively to fertilise the macrogamete. Using the annotation from CryptoDB, Blast2GO and known 
flagellar components from Plasmodium (Sinden et al., 2010), we were able to detect only a few 
genes in our transcriptomes that could potentially be associated with microgametes. Due to the non-
flagellar structure of Cryptosporidium microgametes, it is not surprising that intraflagellar transport 
proteins and radial spoke components are absent from the genome. Few dyneins can be detected in 
the genome, of which a putative heavy chain is barely expressed and the light chain, Tctex1 – one 
of the three potential light chains – is absent in sporozoites (Supplementary Fig. S4A). We cannot 
make firm conclusions about the stage specificity of these genes. Interestingly, out of three genes 
with a gene ontology (GO) term for motile cilium, a gene annotated as a flagellar outer arm protein, 
as well as a hypothetical protein (cgd5_1550 and cgd8_1690, Supplementary Table S1), are 
exclusively expressed in in vivo stages (Supplementary Fig. S4B). The basal body component, 
SAS-6, that in Plasmodium is only present in male gametocytes and plays a role in flagellum 
assembly (Marques et al., 2015), is also present in C. parvum albeit the protein is very 
divergent (Marques et al., 2015). It is expressed in all stages (Supplementary Fig. S4C) and, similar 
to the T. gondii orthologue, seems not to be sexual stage-specific (de Leon et al., 2013). We 
anticipated that C. parvum might possess a HAP2-like protein. HAP2 was first shown to be a male 
gamete fusion factor in Arabidopsis (Liu et al., 2008) and later in Chlamydomonas reinhardtii and 
Plasmodium berghei (Liu et al., 2008), and has also been detected in the sexual stages of E. tenella 
(Walker et al., 2015). Using the amino acid sequence from P. berghei HAP2 for a BLAST search 
in CryptoDB, we identified a protein (CryptoDB ID cgd8_2220) that Blast2GO annotated as a 
male gamete fusion factor (Supplementary Table S1). Using the sequence of the Cryptosporidium 
reinhardtii H/G domain (Liu et al., 2015) to define the boundaries, we aligned putative C. parvum 
HAP2 to C. reinhardtii, P. berghei and T. gondii HAP2 amino acid sequences and found a 
corresponding domain (Supplementary Fig. S4D). However, cgd8_2220 is expressed in all stages of 
C. parvum and at equal levels and, therefore, can be ruled out as a marker for microgametes. On the 
other hand, annotated centrins, which are calcium-binding proteins from the centrosome and have 
been shown in P. falciparum to be upregulated in gametocytes (Mahajan et al., 2008), seem to be 
upregulated in vivo and absent in sporozoites, indicating a potential role in sexual reproduction 
(Supplementary Fig. S4E). Similarly, α- and β-tubulin are upregulated in in vivo stages and not 
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present in sporozoites (Supplementary Fig. S4F). Interestingly, α-tubulin seems to be an orthologue 
of the putative T. gondii α-tubulin I that is upregulated in the feline enteroepithelial stages 
(Ramakrishnan et al., unpublished data). Taken together, we have identified a few in vivo stage-
specific genes that may be associated specifically with microgametes. This stage remains elusive for 
further study without any reproducible in vitro culturing system for sexual stages or specific 
isolation procedures from calf intestines in place. 
 
3.8. Meiosis-specific genes 
During meiosis, programmed double strand breaks (DSBs) occur that have to be repaired 
eventually by homologous recombination, single strand annealing or non-homologous end-joining 
(reviewed in (Norbury and Hickson, 2001)). Using CryptoDB and Blast2GO annotations, we 
identified Rad51, which is involved in homology recognition and strand exchange, and two of its 
homologues as well as a Dmc1-like protein and a Rad54-like protein; Dmc1 is a recombinase whilst 
Rad54 is helicase. All of these genes are expressed at very low levels in the sporozoite but, except 
for cgd4_2050, none of them seem exclusive to in vivo stages (Supplementary Fig. S5A). This is 
especially interesting for the DMC1-like protein, which is described as meiosis-specific in yeast 
(Bishop et al., 1992). Similarly, out of the nucleases, the meiosis-specific spo11 gene is expressed 
in the in vivo and in vitro stages. We identified a putative homologue of Meu13 (cgd2_510) using 
the blastp tool in CryptoDB and the protein sequence from fission yeast. This gene is also expressed 
in the in vivo and in vitro stages, but its putative association partner mcp7 was only detected in the 
early in vivo stage (Supplementary Fig. S5A). Taken together, our results may indicate that 
parasites in in vitro cultures are partially prepared to differentiate to sexual stages on a 
transcriptional level. 
 
3.9. Calcium-dependent protein kinases 
Calcium-dependent protein kinases (CDPKs) are found in plants and protists but not in fungi 
or animals (reviewed in (Harper and Harmon, 2005), rendering them attractive drug targets. 
Calcium signaling in apicomplexans regulates secretion, motility, invasion and egress (reviewed in 
(Billker et al., 2009)). Interestingly, C. parvum and T. gondii CDPK1 can be selectively and 
potently inhibited by a class of kinase inhibitors, which results in a block in host cell invasion 
(Murphy et al., 2010). Etzold et al. (2014) identified seven CDPKs in C. parvum whilst eight genes 
and two CDPK-like proteins had been described previously (Artz et al., 2011). Using Blast2GO, we 
identified an additional CDPK (cgd7_1260, Supplementary Fig. S6A). We used blastp and Smart 
BLAST to identify the closest homologues in other apicomplexans and Arabidopsis thaliana, and 
aligned the predicted serine/threonine protein kinase domains (Supplementary Fig. S6B). Although 
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the catalytic domain can be clearly identified, the kinase function is probably abolished in 
cgd7_1260 due to the lack of a critical aspartate. The C. parvum CDPK1 gene is expressed in all 
stages (Supplementary Fig. S6A). An effective drug against cryptosporidiosis needs to be effective 
against the merozoites/schizonts as well as sexual stages and, thus, this expression profile 
strengthens the notion that CDPK1 is a valid drug target. CDPK6 also is expressed in all stages at 
comparable levels but all the other kinase genes show lower transcript abundance in the 
merozoites/schizonts and sexual stages. CDPK2, 2A and cgd5_2270 are upregulated in sporozoites 
(Supplementary Fig. S6A) and may play an important role in sporozoite motility and invasion. 
 
4. Conclusions  
RNA-Seq analysis of sporozoites and intracellular stages of C. parvum grown in vivo or in 
vitro has identified some genes that are expressed in a stage-specific manner and others whose 
expression is required at all stages of development. These new data sets provide valuable 
information for functional genomic studies that can now be addressed through recent advances in 
transgenics for C. parvum (Vinayak et al., 2015), and may lead to the identification of new, viable 
drug and vaccine targets. 
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Figure legends 
 
Fig. 1. Expression analysis of Cryptosporidium parvum genes in different life cycle stages. (A) 
Sample correlation and pairwise comparison based on DESeq2 normalised (Love et al., 2014) gene 
expression values of all genes with at least five reads in at least one of the samples. Samples were 
clustered using Pearson correlation and hierarchical agglomerative clustering (complete linkage). 
(B) Same as in (A), but excluding sporozoite data. (C) Expression values of genes differentially 
expressed between sporozoites and the populations grown in vivo and in vitro. Out of 3775 genes 
tested, 1612 genes were found to be differentially expressed (false discovery rate (FDR) < 0.01, 
absolute log2 fold change > 2). (D) Expression values of genes differentially expressed between 
populations grown in vivo and populations grown in vitro (517 genes with FDR < 0.01, absolute 
log2 fold change > 1). (C, D) Expression values correspond to genewise Z-scores of scaled, log2-
transformed and DESeq-normalised data. Samples/genes were clustered using euclidean distance 
and hierarchical agglomerative clustering (complete linkage). (E) Number of up- and 
downregulated genes between sporozoites and in vivo/in vitro stages as well as between in vivo and 
in vitro stages. For this comparison, a FDR of < 0.01 and a minimal regulation of 2-fold (log2FC > 
1) was used. sporo, sporozoites; dpi, days p.i. 
 
Fig. 2. Expression analysis of Cryptosporidium parvum COWP genes. Comparative depiction of 
nine COWP mRNA levels (linear scale, normalised reads/kb); inset: expression levels of the six low 
abundance COWP genes (scale: log2 (normalised reads/kb)). dpi, days p.i. 
 
Fig. 3. Expression profiles of the Cryptosporidium parvum ApiAP2 transcription factors. 
Comparative depiction of ApiAP2 mRNA levels (linear scale, normalised reads/kb). (A)  
Comparison of all detected ApiAP2 genes. (B) Comparison of ApiAp2 genes with expression levels 
below 500 normalised reads/kb. dpi, days p.i. 
 
Fig. 4. Expression profiles of the Cryptosporidium parvum mucin and mucin-like gene (Smith et al., 
2005) mRNA levels (normalised reads/kb). dpi, days p.i. 
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Supplementary figure legends 
 
Supplementary Fig. S1. Quality control of RNA using an Agilent Bioanalyzer and Picochip. 
Fluorescence intensity (FU) is plotted against migration time (s) or size (nucleotides (nt)). Parasite-
specific 26S rRNA is indicated by arrows. (A) In vivo RNA samples. Sample 1 of the 4 days p.i. 
sample is a pool of three different samples (fractions). (B) In vitro RNA samples. (C) Sporozoite 
RNA samples. dpi, days p.i.   
 
Supplementary Fig. S2. Microscopy images of Cryptosporidium parvum. (A) H & E staining of 
intestinal section from an infected calf. Parasites are visible at the epithelium (arrowheads). Scale 
bar = 50 µm. (B) Differential interference contrast image of excysted sporozoites (arrowheads).  
 
Supplementary Fig. S3. Pairwise comparison of normalised and log2(x+1)-transformed gene 
expression values of Cryptosporidium parvum. The data was normalised with DESeq2 (with default 
parameters  (Love et al., 2014) using either all samples ("including sporozoites") or only the in vivo 
and in vitro samples ("without sporozoites").  Colours indicate the point densities from high (red) to 
low (blue). Correlation plots are given including or excluding the sporozoite samples. CorP, 
Pearson correlation; CorS, Spearman correlation; n, number of genes plotted. (A) Comparisons of 
sporozoite data with in vivo or in vitro data. (B) Comparisons of in vivo 2 days p.i. data with in 
vivo 4 days p.i. and in vitro data (analysis includes sporozoites). (C) Comparisons of in vivo 4 days 
p.i. data with in vitro data (analysis includes sporozoites). (D) Comparisons of in vitro 2 days p.i. 
data with in vitro 4 days p.i. data (analysis includes sporozoites). (E) Comparisons of in vivo 2 days 
p.i. data with in vivo 4 days p.i. and in vitro data (analysis excludes sporozoites). (F) Comparisons 
of in vivo 4 days p.i. data with in vitro data (analysis excludes sporozoites). (G) Comparisons of in 
vitro 2 days p.i. data with in vitro 4 days p.i. data (analysis excludes sporozoites).  dpi, days p.i.  
Reference 
Love, M.I., Huber, W., Anders, S., 2014. Moderated estimation of fold change and dispersion for 
RNA-seq data with DESeq2. Genome Biol 15, 550. 
 
Supplementary Fig. S4. Differential expression of Cryptosporidium parvum microgamete-
associated genes. (A) Protein sequence alignment of the H/G domain in Hap2 homologues of 
Chlamydomonas reinhardtii, Plasmodium berghei, Toxoplasma gondii, and C. parvum. Bar graph 
showing expression levels of cgd8_2220, the putative C. parvum hap2 (normalised reads). (B-F) 
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Bar graphs showing expression levels of putative microgamete-associated genes (normalised reads 
or normalised reads/kb). dpi, days p.i.  
 
Supplementary Fig. S5. Differential expression of Cryptosporidium parvum meiosis-associated 
genes. (A) Expression values in normalised reads/kb. (B) Life cycle of Cryptosporidium  Sexual 
development takes place after schizogony. Gametocytes release gametes that fuse to a zygote in 
which meiosis takes place. Further development of oocysts containing four sporozoites renders the 
parasite infectious again. Reprinted from Trends in Parasitology, 21(3), Smith, H.V., Nichols, 
R.A.B., Grimason, A.M., Cryptosporidium excystation and invasion: getting to the guts of the 
matter, pp. 133–142, (2005), with permission from Elsevier. dpi, days p.i.  
 
 
Supplementary Fig. S6. Differential expression of calcium-dependent protein kinases in 
Cryptosporidium parvum. (A) Expression values in normalised reads/kb. (B) Alignment of 
serine/threonine protein kinase domains of cgd7_1260 with the domains of CDPK6 from 
Plasmodium falciparum and Toxoplasma gondii as well as of CDPK21 of Arabidopsis thaliana. 
Catalytic residues are highlighted in yellow. In cgd7_1260, a critical aspartate is missing 
(highlighted in red). dpi, days p.i.  
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Highlights: 
•  RNA-Seq was used to compare gene expression of sporozoites versus intracellular 
Cryptosporidium parvum. 
• RNA-Seq revealed C. parvum genes that are expressed in a stage-specific manner and others 
needed at all stages of development. 
• 173 genes (26 for predicted secreted proteins) were upregulated in sporozoites.  
• 1259 genes were upregulated in intracellular stages, across 63 biological processes and 23 
metabolic pathways.  
• Our results allow identification of viable drug and vaccine targets against C. parvum. 
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